Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001720159 | SCV000522782 | likely benign | not provided | 2021-03-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000538918 | SCV000644265 | benign | Tuberous sclerosis 2 | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001012469 | SCV001172926 | likely benign | Hereditary cancer-predisposing syndrome | 2018-10-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000538918 | SCV002041361 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV001012469 | SCV002530973 | benign | Hereditary cancer-predisposing syndrome | 2021-08-23 | criteria provided, single submitter | curation | |
Prevention |
RCV003972617 | SCV004794406 | likely benign | TSC2-related condition | 2019-03-21 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |